Postpartum Hemorrhage Clinical Trial
Official title:
The Effect of Placental Cord Drainage on Postpartum Blood Loss
| Verified date | February 2024 |
| Source | University of Tennessee |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
To determine if placental cord drainage decreases the blood loss after spontaneous vaginal delivery
| Status | Completed |
| Enrollment | 71 |
| Est. completion date | June 1, 2023 |
| Est. primary completion date | June 1, 2023 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 45 Years |
| Eligibility | Inclusion Criteria: - Singleton Gestation - Ages 18-45 - English Speaking - Third Trimester Gestation Exclusion Criteria: - Operative Vaginal Delivery - Multiple Gestation - Cesarean Delivery - Episiotomy - 3rd or 4th degree laceration - Less than the Third Trimester of Pregnancy - Chorioamnionitis - History of Postpartum Hemorrhage - Macrosomic Infant |
| Country | Name | City | State |
|---|---|---|---|
| United States | Regional One Health | Memphis | Tennessee |
| Lead Sponsor | Collaborator |
|---|---|
| University of Tennessee | Sponsor GmbH |
United States,
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186. doi: 10.1097/AOG.0000000000002351. — View Citation
Roy P, Sujatha MS, Bhandiwad A, Biswas B, Chatterjee A. Placental Blood Drainage as a Part of Active Management of Third Stage of Labour After Spontaneous Vaginal Delivery. J Obstet Gynaecol India. 2016 Oct;66(Suppl 1):242-5. doi: 10.1007/s13224-016-0857- — View Citation
Vasconcelos FB, Katz L, Coutinho I, Lins VL, de Amorim MM. Placental cord drainage in the third stage of labor: Randomized clinical trial. PLoS One. 2018 May 2;13(5):e0195650. doi: 10.1371/journal.pone.0195650. eCollection 2018. — View Citation
WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee. Geneva: World Health Organization; 2017 (WHO/MCA/17.10). Licence: CC BY-NC-SA 3.0 IGO.
Wu HL, Chen XW, Wang P, Wang QM. Effects of placental cord drainage in the third stage of labour: A meta-analysis. Sci Rep. 2017 Aug 1;7(1):7067. doi: 10.1038/s41598-017-07722-7. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Qualitative Blood Loss | Total Volume in Underbuttocks Drape - Initial Volume in Drape (amniotic fluid etc) + blood in laparotomy sponges | Through delivery completion, on average 30 minutes | |
| Secondary | Duration of Third Stage of Labor | After neonatal delivery to delivery of the placenta | On average 30 minutes | |
| Secondary | Retained Placenta | Placenta not delivered > 30 minutes | 30 minutes after delivery | |
| Secondary | Postpartum Hemorrhage | Blood Loss Greater than 1000cc | 30 minutes to 1 hour after delivery | |
| Secondary | Blood Loss > 500 cc | Greater than average postpartum blood loss | 30 minutes to 1 hour after delivery | |
| Secondary | Need for Blood Transfusion | In event of HgB <7 or active bleeding | Up to 24 hours postpartum | |
| Secondary | Percent Drop in HgB and Hct | Lab draw following delivery | Up to 48 hours following delivery | |
| Secondary | Additional Uterotonic Administration | Medications administered to stop postpartum bleeding | 30 minutes to 1 hour following delivery | |
| Secondary | Endometritis | Infection of myometrium of uterus | Up to 12 weeks following delivery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03434444 -
In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol
|
N/A | |
| Terminated |
NCT01980173 -
Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care
|
N/A | |
| Not yet recruiting |
NCT06033170 -
Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage
|
N/A | |
| Not yet recruiting |
NCT02319707 -
Management of the Third Stage of Labor
|
Phase 3 | |
| Completed |
NCT02163616 -
Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study
|
Phase 3 | |
| Recruiting |
NCT01600612 -
Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial
|
N/A | |
| Completed |
NCT02079558 -
Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section
|
Phase 2 | |
| Withdrawn |
NCT01108302 -
Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India
|
N/A | |
| Completed |
NCT00097123 -
RCT of Misoprostol for Postpartum Hemorrhage in India
|
N/A | |
| Completed |
NCT02883673 -
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
|
N/A | |
| Completed |
NCT02542813 -
Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers
|
Phase 1 | |
| Completed |
NCT04201665 -
EMG for Uterotonic Efficiency Estimation
|
N/A | |
| Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
| Not yet recruiting |
NCT05501106 -
Reducing Postpartum Hemorrhage After Vaginal Delivery
|
N/A | |
| Completed |
NCT05429580 -
Prophylactic Tranexamic Acid Use After Vaginal Delivery
|
N/A | |
| Terminated |
NCT03064152 -
Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery
|
N/A | |
| Recruiting |
NCT05382403 -
Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage
|
N/A | |
| Completed |
NCT03344302 -
Oxytocin Administration During Cesarean Section
|
Phase 4 | |
| Not yet recruiting |
NCT02853552 -
Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding
|
Phase 4 | |
| Completed |
NCT02910310 -
Introduction of UBT for PPH Management in Three Countries
|
N/A |